Cerebral Palsy, Spastic Quadriplegic, 1
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Cerebral Palsy, Spastic Quadriplegic, 1
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Cerebral Palsy, Spastic Quadriplegic, 1
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Seizures
|
0.160 |
Biomarker
|
phenotype |
HPO |
|
|
|
Cerebral Palsy
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Little's Disease
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Microcephaly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Babinski Reflex
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Scoliosis, unspecified
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hyperreflexia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Flexion contracture
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Spastic Quadriplegia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Global developmental delay
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Intellectual Disability
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Hyperprolactinemia
|
0.300 |
Biomarker
|
disease |
CTD_human |
[Modification of the nigro-striatal system by estrogens and prolactin. Clinical and experimental data].
|
7138674 |
1982 |
Alcoholic Intoxication, Chronic
|
0.350 |
Biomarker
|
disease |
BEFREE |
The test-retest reliability for the age of onset of major depression and panic disorder was excellent, and for phobia, GAD and alcoholism, was acceptable.
|
3261342 |
1988 |
Alcoholic Intoxication, Chronic
|
0.350 |
Biomarker
|
disease |
PSYGENET |
The test-retest reliability for the age of onset of major depression and panic disorder was excellent, and for phobia, GAD and alcoholism, was acceptable.
|
3261342 |
1988 |
Diabetes Mellitus
|
0.300 |
Biomarker
|
group |
RGD |
Cloning, characterization, and autoimmune recognition of rat islet glutamic acid decarboxylase in insulin-dependent diabetes mellitus.
|
1924335 |
1991 |
Diabetes Mellitus, Insulin-Dependent
|
0.100 |
Biomarker
|
disease |
BEFREE |
The expressed rat islet 67-kDa GAD protein is functional and is immunoprecipitated by IDDM sera; it comigrates electrophoretically with the 67-kDa islet autoantigen.
|
1924335 |
1991 |
Diabetes Mellitus, Insulin-Dependent
|
0.100 |
Biomarker
|
disease |
BEFREE |
Although the level of GAD autoantibodies generally decline after IDDM onset, patients with IDDM-associated neuropathies have high levels of antibodies to GAD, years after the appearance of clinical IDDM.
|
1370298 |
1992 |
Neuropathy
|
0.020 |
AlteredExpression
|
group |
BEFREE |
Although the level of GAD autoantibodies generally decline after IDDM onset, patients with IDDM-associated neuropathies have high levels of antibodies to GAD, years after the appearance of clinical IDDM.
|
1370298 |
1992 |
Autoimmune Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
Although it has been confirmed that insulin dependent diabetes mellitus (IDDM) is a kind of autoimmune disease, islet cell autoantibodies (ICAs), insulin autoantibodies (IAA) and anti-GAD-glutamic acid decardaxylase antibodies have been found in the sera of patients with IDDM and immunotherapies have been used in some patients with IDDM, yet the manner in which the dysfunctional immunosystem acts on beta cells and causes damage to them remains to be clarified.
|
8143505 |
1993 |
Diabetes Mellitus, Insulin-Dependent
|
0.100 |
Biomarker
|
disease |
BEFREE |
Although it has been confirmed that insulin dependent diabetes mellitus (IDDM) is a kind of autoimmune disease, islet cell autoantibodies (ICAs), insulin autoantibodies (IAA) and anti-GAD-glutamic acid decardaxylase antibodies have been found in the sera of patients with IDDM and immunotherapies have been used in some patients with IDDM, yet the manner in which the dysfunctional immunosystem acts on beta cells and causes damage to them remains to be clarified.
|
8143505 |
1993 |
Diabetes Mellitus, Insulin-Dependent
|
0.100 |
Biomarker
|
disease |
BEFREE |
The gamma-aminobutyrate-synthesizing enzyme glutamate decarboxylase (GAD; L-glutamate 1-carboxy-lyase, EC 4.1.1.15) is a major target of autoantibodies associated with both early and late stages of pancreatic beta-cell destruction and development of type 1 diabetes.
|
7681990 |
1993 |
Diabetes Mellitus, Insulin-Dependent
|
0.100 |
Biomarker
|
disease |
BEFREE |
A natural history analysis of three individuals showed conversions from ICA which was reactive to GAD to a non-GAD-reactive ICA nearer to their clinical onsets of IDD.
|
8423231 |
1993 |